Most Women Diagnosed With HIV in Pregnancy Retained in Care

Share this content:
Most Women Diagnosed With HIV in Pregnancy Retained in Care
Most Women Diagnosed With HIV in Pregnancy Retained in Care

MONDAY, June 20, 2016 (HealthDay News) -- Most women diagnosed with HIV during pregnancy are still retained in clinical care over the first year postpartum, according to a study published in the July issue of Obstetrics & Gynecology.

Carol-Ann Swain, Ph.D., from the New York State Department of Health in New York City, and colleagues examined initial receipt of HIV-related medical care at 30 days after diagnosis and before delivery and assessed retention of care in 228 HIV-infected women diagnosed during pregnancy.

The researchers found that 74 and 87 percent of women had their initial HIV-related care encounter within 30 days of diagnosis and before delivery, respectively. In the first year postpartum, 70 percent of these women were retained. Women who waited more than 30 days for their initial HIV-related care encounter were more likely diagnosed in the first versus third trimester (29 versus 11 percent) and were younger versus older (<25 years [32 percent] versus ≥35 years [13 percent]). Loss to follow-up was significantly greater in the first year among women diagnosed in the third versus first trimester and for those who had a cesarean versus vaginal delivery (adjusted relative risks, 2.21 and 1.76, respectively). Fifty-eight percent of the 178 women with one or more HIV viral load tests in the first year postpartum had an unsuppressed viral load.

"Despite the high proportion retained in care, many women had poor postpartum virologic control," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »